Brendan Browne

Brendan Browne practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Brendan Browne's NPI, 1063772770, was assigned on May 29, 2012. Brendan Browne graduated from University of Florida College of Medicine in 2013. Brendan Browne holds Georgia license 83667.

Brendan Browne's primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Brendan Browne's primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. Brendan Browne is also affiliated with Emory University Hospital. The medical group on file is Emory Clinic. Dmand AI also links Brendan Browne to 3 more hospitals, 1 clinical lab, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Brendan Browne practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Brendan Browne's primary specialty in the NPI Registry, under taxonomy code 208800000X. Brendan Browne is licensed in Georgia.

CMS data shows 1,145 Medicare services from Brendan Browne across 17 procedure codes in 2024, for 382 Medicare patients. Medicare paid $97,962 for them.

CMS counts 382 Medicare patients who saw Brendan Browne in 2024. The largest group is 65 to 74, with 169 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Brendan Browne's median patient age at 69, with 22% women.

In 2024, Brendan Browne wrote 1,097 Medicare Part D claims for 380 patients. 89% of them were for generic drugs. CMS names the drug for 991 of them, across 19 drugs with 11 or more claims each, at $88,783 in total drug cost. In 2023, CMS named 855 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Brendan Browne for performance year 2024, reported through an alternative payment model (APM). Brendan Browne accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Brendan Browne as offering telehealth. CMS counts 65 procedures of prostate resection by Brendan Browne, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Brendan Browne, published from 2016 to 2025. 2016 was the busiest year, with 3. The most frequent topics are Urologic Surgical Procedures, Male, Carcinoma, Transitional Cell and Lichen Sclerosus et Atrophicus. Brendan Browne has published most often in Urology. Brendan Browne's most frequent co-authors are David Canes, MD, Talia Avigail Helman, MD and Daniel A . Kaufman, MD.

CMS Open Payments shows 56 general payments to Brendan Browne from 7 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 83% of the total. Cook Medical LLC paid the most, $52,059.

Brendan Browne graduated from University of Florida College of Medicine in 2013.